AstraZeneca paused its coronavirus vaccine trial after a participant developed an unexplained illness. The development could potentially delay or derail Covid-19 immunization efforts https://t.co/lGYMMBGP6N pic.twitter.com/sNTjzYgdlF— Bloomberg Technology (@technology) September 9, 2020